Forensic · VYNE
VYNE Therapeutics
No signals triggered in our 36-month window. Most stable large-caps look like this. The $9 report still gets you the full chronology of every filing scanned + a clean-record audit trail.
Bear case preview · free
VYNE Therapeutics Inc. triggered no material red flags across the 36-month scan window: no bankruptcy filings, financial restatements, exchange delistings, sudden C-suite departures, equity dilution events, or disclosed cybersecurity breaches were detected in the dataset. The 0/100 LOW score reflects an absence of acute distress signals rather than positive operational indicators, indicating the algorithm found no acute SEC-reportable risk events within the retrospective period. Any near-term score elevation would require filing of a Form 8-K disclosure, material accounting correction, or significant insider trading activity within the next 30-90 days.
↑ That's free. The $9 report goes deeper: every filing cited by accession number, 36-month chronology, what to watch next.
What we checked
✓ Red flags · 36mo
0 8-K events (bankruptcy, delisting, restatement, auditor, officer)
✓ Cyber · 12mo
0 Item 1.05 disclosures + buried-cyber scan
✓ Dilution · 24mo
0 S-3 + 424B5 filings
✓ Buried events
Item 8.01 sections classified for hidden material disclosures
$9
· one-time · emailed in under a minute
The full bear case on VYNE
Plain-English brief. Every signal cited to the exact SEC filing. 36-month chronology. What changes next.
✓ No-signals refund: if the algorithm finds zero red flags on your ticker, reply "refund" and I send the $9 back same day. No questions.
Not ready to buy? Get a free preview by email instead
We'll email you the top 3 signals on VYNE + a discount code for the full report. No subscription, no spam.
Score another ticker
Not investment advice. Every signal grounded in a specific SEC filing. Companies may respond via info@filingfirehose.com.